Company intelligence / Profile preview
Biom Pharmaceutical
Sarasota, Florida, United Statesbiompharma.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Preclinical
01
Overview
Biom Pharmaceutical has developed several patent-pending technologies focused on modulating the human microbiome to address metabolic and immune diseases as well as hard-to-treat neurological disorders. Its commercialized products include advanced probiotics and longevity supplements. The company’s therapeutic pipeline appears to be in preclinical or early clinical stages with a focus on rare neurological indications such as developmental epileptic encephalopathies and Angelman syndrome. No published late-stage clinical results are available yet.
- Therapeutic areas
- Metabolic DisordersImmunologyNeurologyOther
- Modalities
- Live biotherapeutic product therapyMicrobial therapySmall moleculeNutritional supplement
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Biom Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biom Pharmaceutical.